Catalyst Wire Dossier Catalyst Wire Dossier

Orblid

bevacizumab · Laboratoires Delbert
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Orblid, covering 2026-08-04 to 2026-08-04. Get the full timeline:

Most recent: EMA Application withdrawn: Orblid (bevacizumab) — Laboratoires Delbert

See pricing